Product Information
IMATINIB MESYLATE 400 MG TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $2.8764 per EA under NDC 47335047583. Its NADAC has been published 536 times since May 18, 2016.
FDA first approved this application on Dec 3, 2015.
Strength
400 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335047583
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA078340FDA Approved
12/3/2015
On Market Since
2/1/2016
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 536 times since May 18, 2016, and over the history we have for it it has declined 99.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8764 per EA |
|---|---|
| All-time high | $302.4924 (Jun 15, 2016) |
| All-time low | $1.4080 (Aug 23, 2023) |
| 52-week high | $3.2150 |
| 52-week low | $2.8764 |
| Median price | $4.2023 |
| Average price | $41.3853 |
| Largest weekly change | +100.9% (Mar 18, 2020) |
| Weeks tracked | 536 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 400 MG TAB, manufactured by Sun Pharmaceutical Industries Inc., is $2.8764 per EA (NDC 47335047583), effective Aug 19, 2026.
How has the price of IMATINIB MESYLATE 400 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 400 MG TAB has declined 99.0%. It has been tracked across 536 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 400 MG TAB?
Since May 18, 2016, the NADAC for IMATINIB MESYLATE 400 MG TAB has ranged from a low of $1.4080 (Aug 23, 2023) to a high of $302.4924 (Jun 15, 2016), with a median of $4.2023 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 400 MG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IMATINIB MESYLATE 400 MG TAB, is $2.0356 per EA — about 29% below IMATINIB MESYLATE 400 MG TAB.
Who manufactures IMATINIB MESYLATE 400 MG TAB?
IMATINIB MESYLATE 400 MG TAB (NDC 47335047583) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.